Lucinda H. Stebbins, Director at H&Q LIFE SCIENCES INVESTORS (HQL), bought 1,800 shares at $12.65 ($23K) on 2008-02-25, disclosed to the SEC on 2008-02-27.
Open-market purchase of $23k HQL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| HQL | BUY | 2015-06-29 | $28K | — | Filing → |
| THQ | BUY | 2014-12-04 | $20K | — | Filing → |
| HQH | BUY | 2009-09-11 | $11K | — | Filing → |